Patrick Mahaffy, Clovis CEO (Kathryn Scott Osler/The Denver Post via Getty Images)
That big R&D PARP win Clovis CEO Mahaffy touted a few weeks ago? The FDA isn't buying it
Once again, you’ll have to go to the fine print in an SEC filing to find the bad news that has been steadily killing Clovis …
This article is available only to Premium subscribers
Upgrade to Premium for unlimited access and Premium exclusives.
